Table 1 Demographic characteristics of patients
From: Prognostic factors for ovarian metastases in colorectal cancer patients
All patients (n=67) | Patients who underwent surgery in our center (n=54) | ||
|---|---|---|---|
Variables | Value, N (%) | Variables | Value, N (%) |
Age (year) | Â | HIPEC | Â |
 ≥60 | 49 (73.1%) |  No | 32 (59.3%) |
 <60 | 18 (26.9%) |  Yes | 22 (40.7%) |
Primary cancer | Â | Tumor deposits | Â |
 Left colon cancer | 41 (61.2%) |  None | 29 (53.7%) |
 Right colon cancer | 24 (35.8%) |  Present | 10 (18.5%) |
 Unknown | 2 (3.0%) |  Unknown | 5 (9.3%) |
Pathological type | Â | Primary tumor size | Â |
 Adenocarcinoma | 51 (76.1%) |  <5cm | 29 (53.7%) |
 Non-adenocarcinoma | 16 (23.9%) |  ≥5cm | 14 (35.9%) |
 Unknown | 11 (20.4%) | ||
Grade | Â | Perineural invasion | Â |
 Grade I | 6 (9.0%) |  None | 17 (31.5%) |
 Grade II | 40 (59.7%) |  Present | 30 (55.6%) |
 Grade III | 18 (26.9%) |  Unknown | 7 (13.0%) |
 Unknown | 3 (4.5%) | ||
T stage | Â | Scope Reg LN Sur | Â |
 T0-3 | 14 (20.9%) |  None | 13 (24.1%) |
 T4 | 44 (65.7%) |  Present | 36 (66.7%) |
 Tx | 9 (13.4%) |  Unknown | 5 (9.3%) |
N stage | Â | Scope Reg LN Sur (Number) | Â |
 N0 | 15 (22.4%) |  <4 | 32 (59.3%) |
 N1 | 23(34.3%) |  ≥4 | 17 (31.5% (%)) |
 N2 | 19 (28.4%) |  Unknown | 5 (9.3%) |
 Nx | 10 (14.9%) | ||
Primary tumor size | Â | Metastatic tumor size | Â |
 <5cm | 30 (44.8%) |  ≤15cm | 37 (68.5%) |
 ≥5cm | 15 (22.4%) |  >15cm | 14 (25.9%) |
 Unknown | 22 (32.8%) |  Unknown | 3 (5.6%) |
Time of OM | Â | Time of OM | Â |
 Synchronous | 36 (53.7%) |  Synchronous | 31 (57.4%) |
 Metachronous | 31 (46.3%) |  Metachronous | 23 (42.6%) |
| Â | Â | Number of OM | Â |
 Unilateral | 21 (38.9%) | ||
 Bilateral | 31 (57.4%) | ||
 Unknown | 2 (3.7%) | ||
| Â | Â | Parenchymatous organ metastasis | Â |
 None | 18 (33.3%) | ||
 OM+PM | 14 (25.9%) | ||
 OM+PM+others | 17 (31.5%) | ||
 OM+others | 5 (9.3%) | ||
| Â | Â | Peritoneal metastasis | Â |
 No | 32 (59.3%) | ||
 Yes | 22 (40.7%) | ||
| Â | Â | CA125 | Â |
 ≤ 40 kU/L | 20 (37.0%) | ||
 >40 kU/L | 25 (46.3%) | ||
 Unknown | 9 (16.7%) | ||
| Â | Â | CEA | Â |
 ≤30 mg/L | 32 (59.3%) | ||
 >30 mg/L | 15 (27.8%) | ||
 Unknown | 7 (13.0%) | ||
| Â | Â | CA199 | Â |
 ≤60 kU/L | 31 (57.4%) | ||
 >60 kU/L | 16 (29.6%) | ||
 Unknown | 7 (13.0%) | ||
| Â | Â | PCI | Â |
≤10 | 29 (53.7%) | ||
>10 | 25 (46.3%) | ||
| Â | Â | CC | Â |
 0–1 | 37 (68.5%) | ||
 >1 | 17 (31.5%) | ||